TY - JOUR
T1 - The Changing Paradigms for Breast Cancer Surgery
T2 - Performing Fewer and Less-Invasive Operations
AU - Ollila, David W.
AU - Hwang, E. Shelley
AU - Brenin, David R.
AU - Kuerer, Henry M.
AU - Yao, Katharine
AU - Feldman, Sheldon
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Historically, through the conduct of prospective clinical trials, breast cancer surgeons have performed less radical breast and axillary surgeries with no survival decrement to our patients. Currently, other opportunities exist for the treating breast surgeon to do less. Possibilities include active surveillance for ductal carcinoma in situ, ablative therapy for small primary breast cancers, selective omission of a sentinel node biopsy, and selective elimination of breast surgery after neoadjuvant systemic therapy. Breast surgeons must be leaders in the development and testing of effective therapy with the least intervention possible.
AB - Historically, through the conduct of prospective clinical trials, breast cancer surgeons have performed less radical breast and axillary surgeries with no survival decrement to our patients. Currently, other opportunities exist for the treating breast surgeon to do less. Possibilities include active surveillance for ductal carcinoma in situ, ablative therapy for small primary breast cancers, selective omission of a sentinel node biopsy, and selective elimination of breast surgery after neoadjuvant systemic therapy. Breast surgeons must be leaders in the development and testing of effective therapy with the least intervention possible.
UR - http://www.scopus.com/inward/record.url?scp=85049584209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049584209&partnerID=8YFLogxK
U2 - 10.1245/s10434-018-6618-z
DO - 10.1245/s10434-018-6618-z
M3 - Article
C2 - 29968033
AN - SCOPUS:85049584209
VL - 25
SP - 2807
EP - 2812
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
SN - 1068-9265
IS - 10
ER -
